UBS AM’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-99,744
| Closed | -$625K | – | 2699 |
|
|
2025
Q1 | $625K | Sell |
99,744
-18,059
| -15% | -$113K | ﹤0.01% | 2451 |
|
|
2024
Q4 | $957K | Buy |
117,803
+19,778
| +20% | +$161K | ﹤0.01% | 2381 |
|
|
2024
Q3 | $1.77M | Buy |
98,025
+4,871
| +5% | +$88.1K | ﹤0.01% | 2097 |
|
|
2024
Q2 | $959K | Buy |
93,154
+80,261
| +623% | +$827K | ﹤0.01% | 2390 |
|
|
2024
Q1 | $137K | Hold |
12,893
| – | – | ﹤0.01% | 2487 |
|
|
2023
Q4 | $118K | Buy |
+12,893
| New | +$118K | ﹤0.01% | 2521 |
|
|
2021
Q4 | – | Sell |
-7,514
| Closed | -$241K | – | 2891 |
|
|
2021
Q3 | $241K | Buy |
+7,514
| New | +$241K | ﹤0.01% | 2660 |
|